by rdbiomed | May 26, 2020 | Company Updates
We’re delighted to share the news that Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’. Respiratory Technology Corporation (Restech) is a leader in engineering world... 
by rdbiomed | May 18, 2020 | Company Updates
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns... 
by rdbiomed | Mar 26, 2020 | Company Updates
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending... 
by rdbiomed | Nov 28, 2019 | Company Updates
Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull. As a Senior Laboratory Technician – and Project... 
by rdbiomed | Nov 21, 2019 | Company Updates
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading... 
by rdbiomed | Nov 11, 2019 | Company Updates, LPR
Peptest has been described as a ‘cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical...
Recent Comments